Medtech company Healint is partnering with the Saitama Medical University Hospital in Japan to test how artificial intelligence could be used to diagnose migraines.
The study is powered by Healint's Migraine Buddy platform for data. The migraine tracking platform has 3.5 million users, according to an April 27 Healint news release.
The study will examine how AI could diagnose patients, select treatments and identify possible fatal conditions.